New patent expiration for Novo Nordisk drug NOVOLOG MIX 70/30 FLEXPEN

Annual Drug Patent Expirations for NOVOLOG+MIX+70%2F30+FLEXPEN Novolog Mix 70/30 Flexpen is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers.…

The post New patent expiration for Novo Nordisk drug NOVOLOG MIX 70/30 FLEXPEN appeared first on DrugPatentWatch.

Comments are closed.